Tozaro
Life Sciences • East of England • Early Stage
Tozaro (previously MIP Discovery) designs and develops synthetic affinity reagents, with the aim of enhancing complex cell and gene therapy processes.
Company
information
Total BGF investment
£2 million
Investment date
July 2020
Head office
Bedfordshire